drugset
Drugs / VEGFR1-A24-1084
last change Apr 2009 re-read 3 minutes ago

VEGFR1-A24-1084

Peptide

Developed for
malignant pancreatic neoplasm
Investigated by
Human Genome Center, Institute of Medical Science, University of Tokyo · Tokyo University

Trials 1

today NCT00683358 · Ph 1/2
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00683358 May 2008 → Apr 2009 malignant pancreatic neoplasm Tokyo University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VEGFR1-A24-1084 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00683358 ↗
Modality Peptide “VEGFR1-derived peptide” NCT00683358 ↗
Route Subcutaneous “will be subcutaneously injected” NCT00683358 ↗